Related references
Note: Only part of the references are listed.Localized Cutaneous Adverse Event Induced by Anastrozole as Adjuvant Treatment for Breast Cancer: A Case Report
Aya Tanaka et al.
CASE REPORTS IN DERMATOLOGY (2019)
Patient Case Lessons: Endocrine Management of Advanced Breast Cancer
Nicholas J. Robert et al.
CLINICAL BREAST CANCER (2018)
Estrogen receptor agonists/antagonists in breast cancer therapy: A critical review
A. Jameera Begam et al.
BIOORGANIC CHEMISTRY (2017)
Aromatase inhibitors induced autoimmune disorders in patients with breast cancer: A review
George Zarkavelis et al.
JOURNAL OF ADVANCED RESEARCH (2016)
Adjuvant aromatase inhibitor therapy in early breast cancer: what factors lead patients to discontinue treatment?
Luca Moscetti et al.
TUMORI (2015)
Adjuvant aromatase inhibitor therapy in early breast cancer: what factors lead patients to discontinue treatment?
Luca Moscetti et al.
TUMORI (2015)
Letrozole-induced necrotising leukocytoclastic small vessel vasculitis: First report of a case in the UK
Pirunthan Pathmarajah et al.
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS (2015)
Cutaneous leukocytoclastic vasculitis associated with letrozole
Antonia Digklia et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2014)
Letrozole-Induced Very Early Systemic Sclerosis in a Patient With Breast Cancer: A Case Report
Gabriel Pokhai et al.
ARCHIVES OF RHEUMATOLOGY (2014)
Aromatase inhibitor-induced skin adverse reactions: exemestane-related cutaneous vasculitis
S. Santoro et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian study
G. Mustacchi et al.
ANNALS OF ONCOLOGY (2009)
Accelerated Cutaneous Nodulosis Associated with Aromatase Inhibitor Therapy in a Patient with Rheumatoid Arthritis
Jeannie Chao et al.
JOURNAL OF RHEUMATOLOGY (2009)
The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites
V. Ruocco et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Cutaneous vasculitis in breast cancer treated with chemotherapy
Maida Wong et al.
CLINICAL IMMUNOLOGY (2008)
Anastrozole-induced subacute cutaneous lupus erythematosus
M. Trancart et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: Case reports and review of the literature
Komal Jhaveri et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on letrozole or anastrozole. A phase II trial conducted by the Hellenic Group of Oncology (HELGO)
C Gennatas et al.
TUMORI JOURNAL (2006)
Cutaneous vasculitis developed in a patient with breast cancer undergoing aromatase inhibitor treatment
H Shoda et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Share Paper
